Treating Aggressive Cutaneous Squamous Cell Carcinomas
Dr. Debottam Sinha, Dr. Gishan Ratnayake, Prof. Erik Thompson
Skin cancer
Cutaneous squamous cell carcinoma (cSCC) is a common and challenging skin cancer to treat, especially given its potential to affect large areas of skin. While traditional treatments like radiotherapy (RT) can be effective, they often cause significant side effects.
We are exploring a promising new treatment strategy to use cold atmospheric plasma therapy, delivered in the form of Plasma Activated Medium (PAM). This therapy can be applied directly to the skin and may enhance the effectiveness of RT with minimum cell toxicity. Our research aims to determine whether PAM alone or in combination with RT can improve outcomes for cSCC; potentially offering a non-invasive, safe treatment option for patients suffering from chronic skin cancers.
This research is vital in Queensland, where skin cancer rates are highest globally.